Who's buying AgomAb Therapeutics NV?

AGMB insider buying, 13F and 13D filings

• Oct 22, 2026Insider buy
  David R Epstein (Director): Bought $89K on the open market
  10.0K shares at ~$8.88, traded 2026-10-21. Now holds 25.0K shares (stake up 67%).
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.